Sphingosine 1-phosphate induces antimicrobial activity both in vitro and in vivo.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 15143482.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Sphingosine 1-phosphate (S1P), a polar sphingolipid metabolite, is involved in a wide spectrum of biological processes, including Ca(++) mobilization, cell growth, differentiation, motility, and cytoskeleton organization. Here, we show a novel role of S1P in the induction of antimicrobial activity in human macrophages that leads to the intracellular killing of nonpathogenic Mycobacterium smegmatis and pathogenic M. tuberculosis. Such activity is mediated by host phospholipase D, which favors the acidification of mycobacteria-containing phagosomes. Moreover, when it was intravenously injected in mycobacteria-infected mice, S1P reduced mycobacterial growth and pulmonary tissue damage. These results identify S1P as a novel regulator of the host antimicrobial effector pathways.
Medical subject headings
- Lysophospholipids
- Macrophages, Alveolar
- Mycobacterium smegmatis
- Mycobacterium tuberculosis
- Sphingosine
- Tuberculosis, Pulmonary